RECALL ALERT: FDA has announced a voluntary recall of Montelukast tablets by Camber Pharmaceuticals. Sealed bottles labeled as montelukast sodium tablets, 10 milligram, 30-count bottle were found to instead contain 90 tablets of Losartan Potassium Tablets, 50 mg.
The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Inc., Piscataway, N.J. Sealed bottles labeled as montelukast sodium tablets, 10 milligram, 30-count bottle from Camber were found to instead contain 90 tablets of Losartan Potassium Tablets, 50 mg.
This tablet mix-up may pose a safety risk as taking losartan tablets when not prescribed has the potential to cause renal dysfunction, elevated potassium levels and low blood pressure. This risk is especially high for pregnant women taking the allergy and asthma medication montelukast because losartan, which is indicated to treat high blood pressure, could harm or kill the fetus. The FDA recommends that consumers who have this recalled product should contact their health care provider or pharmacist immediately.
This recall is not related to the recent valsartan recalls that were due to an impurity, N-nitrosodimethylamine (NDMA).
“We want to ensure that patients who take montelukast are aware of this recall due to the serious risks associated with taking losartan in its place,” said Donald D. Ashley J.D., director of the office of compliance in the FDA’s center for drug evaluation and research. “Patients who take prescription drugs expect and deserve to have the medication their doctor prescribed.”
Read the full press release to learn more. http://bit.ly/2wKHoex
Receive our board-certified approved periodic news, tips and articles.
Thank you for subscribing.
Something went wrong.
Your subscription is used only for the purpose of direct communication with our office.
Join the mission to make a positive and lasting impact on the lives of children with food allergies.… twitter.com/i/web/status/10439…
RECALL ALERT: FDA has announced a voluntary recall of Montelukast tablets by Camber Pharmaceuticals. Read more.… twitter.com/i/web/status/10436…